Reaktionsgleichung
[CH3:1][C:2]1[S:3][C:4]2[C:10]([O:11][CH:12]=[C:13]3[CH2:15][O:14]3)=[CH:9][CH:8]=[CH:7][C:5]=2[N:6]=1.[NH2:16][CH:17]1[CH2:20][N:19]([CH:21]([C:28]2[CH:33]=[CH:32][CH:31]=[CH:30][CH:29]=2)[C:22]2[CH:27]=[CH:26][CH:25]=[CH:24][CH:23]=2)[CH2:18]1>O1CCOCC1.C(O)C>[CH:21]([N:19]1[CH2:20][CH:17]([NH:16][CH2:15][CH:13]([OH:14])[CH2:12][O:11][C:10]2[C:4]3[S:3][C:2]([CH3:1])=[N:6][C:5]=3[CH:7]=[CH:8][CH:9]=2)[CH2:18]1)([C:28]1[CH:33]=[CH:32][CH:31]=[CH:30][CH:29]=1)[C:22]1[CH:23]=[CH:24][CH:25]=[CH:26][CH:27]=1Komponenten
4
Versuchsvorschrift
The title compound was prepared according to Method A from 2-methyl-7-(oxiranyl-2-ylmethoxy)benzothiazole and 3-amino-1-benzhydrylazetidine with dioxane/ethanol (1:1) as the solvent. mp 55° C.; LSIMS m/z 460. The 3-amino-1-benzhydrylazetidine was prepared as described in Preparation 96.
Aufarbeitung
- customThe 3-amino-1-benzhydrylazetidine was prepared
- customas described in Preparation 96
Quellen und Nachweise
- ORD-Eintrag
- ord-09b7a2c5efbc48d7901f72b7881882cf
- Quelldatensatz
- uspto-grants-2000_10
- Patentnummer
- US06130217
Verknüpfte Notizen
Wird geladen…